Biofrontera Inc. (BFRI) Q1 2025 Earnings Call Transcript


Biofrontera Inc. (NASDAQ:BFRI) Q1 2025 Earnings Conference Call May 16, 2025 10:00 AM ET

Company Participants

Andrew Barwicki – IR Representative
Hermann Luebbert – CEO, Chairman, & Founder
Fred Leffler – CFO

Conference Call Participants

Jonathan Aschoff – ROTH Capital
Bruce Jackson – The Benchmark Company

Operator

Good day, and welcome to the Biofrontera’s First Quarter 2025 Financial Results and Business Update Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note, this event is being recorded.

I would now like to turn the conference over to Andrew Barwicki. Please go ahead.

Andrew Barwicki

Good morning, and welcome to Biofrontera Inc.’s first quarter fiscal year 2025 financial results and business update conference call.

Please note that certain information discussed during today’s call by management is covered under the safe harbor provisions of the Private Securities Litigation Reform Act. We caution listeners that Biofrontera’s management will be making forward-looking statements and that actual results may differ materially from those stated or implied by these forward-looking statements, due to risks and uncertainties associated with the company’s business.

All risks and uncertainties are detailed in and are qualified by the cautionary statements contained in Biofrontera’s press releases and SEC filings. Also, this conference call contains time sensitive information that is accurate only as of the date of this live broadcast, May 16, 2025. Biofrontera undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this conference call, except as required by law.

During today’s call, there will be references to certain non-GAAP measures. Biofrontera believes these measures provide useful information for investors, yet should not be considered as a substitute for GAAP nor should they be viewed as a substitute for



#Biofrontera #BFRI #Earnings #Call #Transcript

Leave a Reply

Your email address will not be published. Required fields are marked *